Current position:Home > Selling > CAS 112809-51-5 Letrozole/melissa@ycphar.com
Add to My Favorites

CAS 112809-51-5 Letrozole/melissa@ycphar.com

  • CAS No.: 112809-51-5
  • Purity: 99%
  • Price: USD 0.1~10/Kilograms
  • Weight: 285.30274
  • Place of Orign: WuChang,Hubei,China
Ms.Melissa Chang

Supplier Details

View the Seller's Store
Product Details
Company Profile

Item specifics

  • Product Name.:CAS 112809-51-5 Letrozole/melissa@ycphar.com
  • CAS No: 112809-51-5
  • Weight: 285.30274
  • Formula: C17H11N5
  • Melting Point: 181-183 ºC
  • Boiling Point: 374.4 °C at 760 mmHg
  • Density: 1.21g/cm3

Details

CAS 112809-51-5 Letrozole/melissa@ycphar.com


Product Name:Letrozole
Alias: Femara, Lelrozol, TROZET,Letroz,Lelroz, letrozolex
CAS Registry Number:112809-51-5
Purity: 98%
MF: C17H11N5
MW: 285.3
Appearance: White crystalline powder.
Grade:Pharmaceutical Grade

Letrozole Profile

Letrozoles are non suicidal Aromatase Inhibitors, belonging to the third generation of aromatase inhibitors. They are administered orally and hold the approval of the Food and Drug Administration of the United States (FDA) for use in treating two particular kinds of breast cancer. One is the case when hormone receptor positive breast cancer develops locally or is contracted through metastatis. The other is a similar case but when the cancer is of the estrogen receptor unknown category.

The estrogen receptor unknown category refers to those breast cancer conditions where the role of estrogens can not be determined with certainty. In these cases, it is impossible to predict if estrogen caused the cancer in the first place or if it would complicate and worsen the cancer further. Letrozoles are used in the treatment of such cancer conditions in post menopausal women. It is however rare that Letrozole be required for treating the post menopausal estrogen receptor unknown cancer, first-line. In most cases, it is used only after the usual first-line treatments using Selective Estrogen Receptor Modulator drugs like the Nolvadex have failed to show any positive effects.

Letrozole Effect

Letrozole is a powerful Aromatase Inhibitor that was developed to fight breast cancer. For athletes and bodybuilders, it is a drug used to combat the estrogenic side effects of anabolic steroids water-retention, acne and gynocomastia. It will also raise testosterone levels because of the lowered estrogen in the body. Side effects from Letrozole include a lowered sex drive and continuous use can lead to lowered lipid function and an impaired immune system.

Dosages and Half Life

The half life is approximately 2-4 days. Dosages vary quite a bit, 0.25mg up to 1mg every day or every other day is a good starting dose. It’s best to be conservative with the dosage because if you overdose the sides can be harsh.
CAS 112809-51-5 Letrozole/melissa@ycphar.com

Permanent link:

Company Related ProductsView the Seller's Products

copy of CAS 5197-58-0 Stenbolone Pharmaceutical Intermediates

CAS No: 5197-58-0

Purity: 99%

Min quantity: null null

Price: 0.1 ~ 10 USD

Description: CAS 5197-58-0 Stenbolone Product Name: Methylstenbolone,Stenbolone Alias: Methylstenbolone,Estembolona,Stenbolonum CAS No.: 5197-58-0 Molecular Formula: C20H30O2 Molecular Weight: 302.455 M.P.: 154-156°C Purity: 98% Appearance: white or white crystal...

Detail more >>

copy of CAS 3625-07-8 Mebolazine Pharmaceutical Intermediates

CAS No: 3625-07-8

Purity: 99%

Min quantity: null null

Price: 0.1 ~ 10 USD

Description: CAS 3625-07-8 Mebolazine Product Name:Mebolazine,Dimethazine Alias:DMZ,Dostalon,Roxilon,Diarethyl,Dimetazin,Dimetina CAS NO.:3625-07-8 Molecular Formula:C42H68N2O2 Molecular Weight:633.0015 Appearance:White Crystalline Powder Grade:Pharmaceutical Gra...

Detail more >>
Send message to this supplier

Ms.Melissa Chang
View the Seller's Store
- Enter between 20 to 3,000 characters. English only.
Your message must be between 20-2000 characters.English only.

Related Products